NCT01368926View on ClinicalTrials.gov

A Pharmacokinetic Study of RO4917523 in Healthy Japanese and Caucasian Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Healthy Volunteer
Interventions
DRUG

RO4917523

single oral doses

DRUG

RO4917523

multiple oral doses

DRUG

placebo

oral doses

Trial Locations (1)

10016

New York

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01368926 - A Pharmacokinetic Study of RO4917523 in Healthy Japanese and Caucasian Subjects | Biotech Hunter | Biotech Hunter